NORTHERN TRUST CORP - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 47 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$95,000
+58.3%
46,664
+11.1%
0.00%
Q1 2022$60,000
-11.8%
42,0000.0%0.00%
Q4 2021$68,000
-49.3%
42,0000.0%0.00%
Q3 2021$134,000
-21.6%
42,000
+21.2%
0.00%
Q2 2021$171,000
-20.1%
34,658
+33.7%
0.00%
Q1 2021$214,000
+613.3%
25,923
+60.1%
0.00%
Q4 2020$30,000
+66.7%
16,192
-22.1%
0.00%
Q3 2020$18,00020,7820.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2021
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders